PubRank

Gerard M Turino

Author PubWeight™ 24.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 2006 5.29
2 Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med 2009 1.70
3 The effect of secondhand smoke exposure on markers of elastin degradation. Chest 2011 1.41
4 Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency. Thorax 2007 1.12
5 Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. Chest 2003 1.09
6 Measurements of desmosine and isodesmosine by mass spectrometry in COPD. Chest 2007 1.02
7 The detection and quantitation of free desmosine and isodesmosine in human urine and their peptide-bound forms in sputum. Proc Natl Acad Sci U S A 2003 1.00
8 Can exogenously administered hyaluronan improve respiratory function in patients with pulmonary emphysema? Chest 2004 0.90
9 Aerosolized hyaluronan limits airspace enlargement in a mouse model of cigarette smoke-induced pulmonary emphysema. Exp Lung Res 2005 0.89
10 Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC-MS/MS as biomarkers for elastin degradation. J Chromatogr B Analyt Technol Biomed Life Sci 2011 0.83
11 Therapeutic effects of hyaluronan on smoke-induced elastic fiber injury: does delayed treatment affect efficacy? Lung 2010 0.83
12 Characterization of peptide fragments from lung elastin degradation in chronic obstructive pulmonary disease. Exp Lung Res 2010 0.83
13 Association of cigarette smoking and CRP levels with DNA methylation in α-1 antitrypsin deficiency. Epigenetics 2012 0.81
14 The effect of tiotropium therapy on markers of elastin degradation in COPD. Respir Res 2009 0.79
15 COPD and biomarkers: the search goes on. Thorax 2008 0.78
16 Alpha-1 antitrypsin augmentation therapy and biomarkers of elastin degradation. COPD 2013 0.78
17 Therapeutic gains of prolonged bronchial dilatation in chronic obstructive pulmonary disease. Ann Intern Med 2005 0.77
18 Proteases in COPD: a critical pathway to injury. Chest 2007 0.76
19 Desmosine and Isodesmosine as a Novel Biomarker for Pulmonary Arterial Hypertension: A Pilot Study. Am J Ther 2015 0.76
20 The effect of lysozyme on elastase-mediated injury. Exp Biol Med (Maywood) 2002 0.75
21 Stable deuterium internal standard for the isotope-dilution LC-MS/MS analysis of elastin degradation. Anal Biochem 2013 0.75
22 Synergistic effect of hydrogen peroxide and elastase on elastic fiber injury in vitro. Exp Biol Med (Maywood) 2006 0.75
23 Alpha1-antitrypsin deficiency: lessons from longevity. Chest 2009 0.75
24 Synthesis and LC-MS/MS analysis of desmosine-CH2, a potential internal standard for the degraded elastin biomarker desmosine. Org Biomol Chem 2014 0.75